-
Mashup Score: 2
71K likes, 1,388 comments – leannehainsby on April 21, 2024: “So proud of us. Today, we completed the 2024 London Marathon 🎉🙌🏻 What’s even more amazing than that is that we have (currently…”.
Source: www.instagram.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29BCTRP Pilot Grants | OSUCCC Breast Cancer - 11 day(s) ago
“Inflammation and Lymphedema” William Carson, Roman Skoracki, and Karen Hock “Tissue Factor (CD142) as a New Target for Antibody-Drug Conjugate Treatment of Triple-Negative Breast Cancer” Zhiwei Hu, Robert Wesolowski, and Kai Johnson “Spatial Association of Tumor Microbes and the Tumor Microenvironment in Breast Cancer Subtypes” Sachin Jhawar and Dan Spakowicz “Effect of a MIND Diet Intervention on DNA Methylation Patterns in Breast Cancer Survivors: Analysis of Patient Specimens from the MIND-BC Pilot
Source: u.osu.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 48Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers - 2 month(s) ago
Blood-based liquid biopsy is increasingly used in clinical care of patients with cancer, and fraction of tumor-derived DNA in circulation (tumor fraction; TFx) has demonstrated clinical validity across multiple cancer types. To determine TFx, shallow whole-genome sequencing of cell-free DNA (cfDNA) can be performed from a single blood sample, using an established computational pipeline (ichorCNA), without prior knowledge of tumor mutations, in a highly cost-effective manner. We describe assay validation of this approach to facilitate broad clinical application, including evaluation of assay sensitivity, precision, repeatability, reproducibility, pre-analytic factors, and DNA quality/quantity.
Source: www.jmdjournal.orgCategories: General Medicine News, Hem/OncsTweet-
ctDNA 'tumor fraction' is a simple concept & remains a relevant biomarker in diverse cancers. @broadinstitute Genomics Platform & @StoverLab validated shallow WGS assay sensitivity, precision, repeat-/reproducibility, & pre-analytic factors - in @JMDiagn https://t.co/drKNlYegDQ https://t.co/Eyq1yK7mdU
-
-
Mashup Score: 36Pelotonia | Profile - 2 month(s) ago
Pelotonia is a community that is determined to see an end to cancer. Together, we’ve saved countless lives. Help us save more.
Source: www.pelotonia.orgCategories: General Medicine News, Hem/OncsTweet-
Honored to speak at @Pelotonia 2024 'high rollers' kickoff for AMAZING riders 🚴🏻♀️ who raise >$5000 to #EndCancer! I was so inspired...that I am joining them! If you are moved to support my journey: https://t.co/ARkBxr8mnw 📷: Signing up w @David_Cohn_MD @DeanBradfordMD @Zihai https://t.co/qO2m0Oc5eY
-
-
Mashup Score: 22
Breast cancer experts from Ohio State and invited speakers will bring you the latest insights and practical guidance as presented at the 2023 San Antonio Breast Cancer Symposium.
Source: cancer.osu.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22
Breast cancer experts from Ohio State and invited speakers will bring you the latest insights and practical guidance as presented at the 2023 San Antonio Breast Cancer Symposium.
Source: cancer.osu.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients with Cancer - 5 month(s) ago
Background Tumor genomic testing (TGT) has become standard-of-care for most patients with advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT is variable or frequently omitted. The purpose of this study was to evaluate the impact of a concise (3-4 minute) video for patient education prior to TGT. Methods Based on a quality improvement cycle, an animated video was created to be applicable to any cancer type, incorporating culturally diverse images, available in English and Spanish. Patients undergoing standard-of care TGT were enrolled at a tertiary academic institution and completed validated survey instruments immediately prior to video viewing (T1) and immediately post-viewing (T2). Instruments included: 1) 10-question objective genomic knowledge/understanding; 2) 10-question video message-specific knowledge/recall; 3) 11-question Trust in Physician/Provider; 4) attitudes regarding TGT. The primary objective was change in outcomes from before to
Source: www.medrxiv.orgCategories: General Medicine News, Hem/OncsTweet-
@maryam_lustberg @LeighaSenter And preprint of 150 pt prospective study (NCT05215769) showing that by spending 4 minutes viewing the video, patients have better understanding about: -Potential for incidental germline findings -Risks/benefits of testing -Insurance coverage of testing https://t.co/siz1N6Czu8
-
-
Mashup Score: 5Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions - 5 month(s) ago
To evaluate the impact of targeted DNA sequencing on selection of cancer therapy for patients with metastatic breast cancer (MBC).In this prospective, single-center, single-arm trial, patients with MBC were enrolled within 10 weeks of starting a new therapy. …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 20Tumor Testing: What Do I Need to Know? - 5 month(s) ago
Tumor Genomic TestingFor many patients with cancer, a piece of their tumor or a blood sample (‘liquid biopsy’) is sent to look for mutations in the cancer cells that may impact treatment. Learn more about ‘tumor genomic testing’ below: Copyright © 2023. The Ohio State University. All rights reserved. No part of this video may be reproduced, displayed, modified, or…
Source: www.tumor-testing.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 42Atezolizumab in Combination With Carboplatin In Metastatic TNBC - 5 month(s) ago
This randomized clinical trial examines the efficacy of adding atezolizumab to treatment with carboplatin in patients with metastatic triple-negative breast cancer (TNBC), and the clinical or molecular correlates associated with disease response.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
Pumped that my @onepeloton 💯instructor @BenjaminAlldis completed the @LondonMarathon supporting @BreastCancerNow! @BreastCancerNow supports some of the most impactful #breastcancer research in the 🌎 - eg Nick Turner, Andy Tutt et al @ICR_London 💯💯 https://t.co/Fbw11kUCYE